Acute pneumonitis after subcutaneous injection of BIO-ALCAMID® in breast
Filling materials are used to correct soft tissue deficits. Local and systemic complications are described when these substances are applied. The polyalkylamide gel (Bio-alcamid) used as filler material has been associated with complications at the facial level, while at the pulmonary level they hav...
| Main Authors: | , , , |
|---|---|
| Format: | Article |
| Language: | Spanish |
| Published: |
Universidad Ricardo Palma
2023-01-01
|
| Series: | Revista de la Facultad de Medicina Humana |
| Subjects: | |
| Online Access: | http://revistas.urp.edu.pe/index.php/RFMH/article/view/4992 |
| _version_ | 1797849367606984704 |
|---|---|
| author | Renzo Villanueva-Villegas Anita Trigoso-Gutiérrez Piero Castillo-Gutierrez Juan Salas-López |
| author_facet | Renzo Villanueva-Villegas Anita Trigoso-Gutiérrez Piero Castillo-Gutierrez Juan Salas-López |
| author_sort | Renzo Villanueva-Villegas |
| collection | DOAJ |
| description | Filling materials are used to correct soft tissue deficits. Local and systemic complications are described when these substances are applied. The polyalkylamide gel (Bio-alcamid) used as filler material has been associated with complications at the facial level, while at the pulmonary level they have not been reported in the literature. We present the case of a patient who consulted due to sudden progressive dyspnea hours after the subcutaneous injection of Bio-alcamid in the breasts. After the clinical evaluation and the result of auxiliary tests, the diagnosis of acute pneumonitis secondary to the injection of this substance is concluded. Follow-up of the case was carried out with favorable evolution and resolution of symptoms after three months. We conclude that Bio-alcamid can generate complications at the pulmonary level, therefore, the intervention of public policies that regulate its use, commercialization and application by non-medical personnel is necessary. |
| first_indexed | 2024-04-09T18:42:49Z |
| format | Article |
| id | doaj.art-5f16294808994c8ebafbd5fadd0f7fef |
| institution | Directory Open Access Journal |
| issn | 1814-5469 2308-0531 |
| language | Spanish |
| last_indexed | 2024-04-09T18:42:49Z |
| publishDate | 2023-01-01 |
| publisher | Universidad Ricardo Palma |
| record_format | Article |
| series | Revista de la Facultad de Medicina Humana |
| spelling | doaj.art-5f16294808994c8ebafbd5fadd0f7fef2023-04-10T18:59:19ZspaUniversidad Ricardo PalmaRevista de la Facultad de Medicina Humana1814-54692308-05312023-01-0123113213710.25176/RFMH.v23i1.4992Acute pneumonitis after subcutaneous injection of BIO-ALCAMID® in breastRenzo Villanueva-Villegas0https://orcid.org/0000-0002-7820-0016Anita Trigoso-Gutiérrez1https://orcid.org/0000-0002-4616-9536Piero Castillo-Gutierrez2https://orcid.org/0000-0003-4141-7964Juan Salas-López3https://orcid.org/0000-0003-3686-6837Instituto de Investigación de Ciencias Biomédicas (INICIB), Facultad de Medicina Humana. Universidad Ricardo Palma (URP), Lima – Perú.Estudiante de la Facultad de Medicina Humana, Universidad Nacional Mayor de San Marcos.Estudiante de la Facultad de Medicina Humana, Universidad Nacional Mayor de San Marcos.Instituto de Investigación de Ciencias Biomédicas (INICIB), Facultad de Medicina Humana. Universidad Ricardo Palma (URP), Lima – Perú.Filling materials are used to correct soft tissue deficits. Local and systemic complications are described when these substances are applied. The polyalkylamide gel (Bio-alcamid) used as filler material has been associated with complications at the facial level, while at the pulmonary level they have not been reported in the literature. We present the case of a patient who consulted due to sudden progressive dyspnea hours after the subcutaneous injection of Bio-alcamid in the breasts. After the clinical evaluation and the result of auxiliary tests, the diagnosis of acute pneumonitis secondary to the injection of this substance is concluded. Follow-up of the case was carried out with favorable evolution and resolution of symptoms after three months. We conclude that Bio-alcamid can generate complications at the pulmonary level, therefore, the intervention of public policies that regulate its use, commercialization and application by non-medical personnel is necessary.http://revistas.urp.edu.pe/index.php/RFMH/article/view/4992acute pneumonitisbiopolymerfiller materialdyspnea |
| spellingShingle | Renzo Villanueva-Villegas Anita Trigoso-Gutiérrez Piero Castillo-Gutierrez Juan Salas-López Acute pneumonitis after subcutaneous injection of BIO-ALCAMID® in breast Revista de la Facultad de Medicina Humana acute pneumonitis biopolymer filler material dyspnea |
| title | Acute pneumonitis after subcutaneous injection of BIO-ALCAMID® in breast |
| title_full | Acute pneumonitis after subcutaneous injection of BIO-ALCAMID® in breast |
| title_fullStr | Acute pneumonitis after subcutaneous injection of BIO-ALCAMID® in breast |
| title_full_unstemmed | Acute pneumonitis after subcutaneous injection of BIO-ALCAMID® in breast |
| title_short | Acute pneumonitis after subcutaneous injection of BIO-ALCAMID® in breast |
| title_sort | acute pneumonitis after subcutaneous injection of bio alcamid r in breast |
| topic | acute pneumonitis biopolymer filler material dyspnea |
| url | http://revistas.urp.edu.pe/index.php/RFMH/article/view/4992 |
| work_keys_str_mv | AT renzovillanuevavillegas acutepneumonitisaftersubcutaneousinjectionofbioalcamidinbreast AT anitatrigosogutierrez acutepneumonitisaftersubcutaneousinjectionofbioalcamidinbreast AT pierocastillogutierrez acutepneumonitisaftersubcutaneousinjectionofbioalcamidinbreast AT juansalaslopez acutepneumonitisaftersubcutaneousinjectionofbioalcamidinbreast |